'Incredible' Response Rates in Atopic Dermatitis With Drugs From China

(MedPage Today) -- DENVER -- Biological agents targeting interleukin-4 receptor alpha (IL-4Rα) in atopic dermatitis (AD) achieved rapid and substantial improvement in up to three-fourths of patients, according to randomized trials from China...
Source
MedPage Today
Opens original article in a new tab



